Benzinga | Nov 12, 2021 08:24AM EST

Aptevo Therapeutics Q3 EPS $(1.42) Up From $(2.15) YoY, Sales $3.10M Up From $1.46M YoY

Aptevo Therapeutics (NASDAQ:APVO) reported quarterly losses of $(1.42) per share. This is a 33.95 percent increase over losses of $(2.15) per share from the same period last year. The company reported $3.10 million in sales this quarter. This is a 111.62 percent increase over sales of $1.46 million the same period last year.